Financhill
Sell
44

TXG Quote, Financials, Valuation and Earnings

Last price:
$16.74
Seasonality move :
-12.36%
Day range:
$16.25 - $16.86
52-week range:
$6.78 - $20.34
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.21x
P/B ratio:
2.69x
Volume:
939.6K
Avg. volume:
2.5M
1-year change:
13.77%
Market cap:
$2.1B
Revenue:
$610.8M
EPS (TTM):
-$0.62

Earnings Data

Next earnings date for TXG
Feb 11
2026
Most recent earnings per share
-$0.22
Missed by $0.15
(Nov 6/2025)
Consensus Estimate
-$0.07
(Nov 6/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

TXG Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/11/2026 Q4 $156M -- -- -$0.06 --
11/06/2025 Q3 $142.5M $149M -$0.22 -$0.07 -$0.15
08/07/2025 Q2 $139.5M $172.9M $0.28 -$0.08 $0.36
05/08/2025 Q1 $132.5M $154.9M -$0.28 -$0.29 $0.01
02/12/2025 Q4 $165M $165M -$0.40 -$0.11 -$0.30
10/29/2024 Q3 $151.7M $151.7M -$0.30 -$0.26 -$0.04
08/08/2024 Q2 $150.1M $153.1M -$0.32 -$0.23 -$0.09
04/30/2024 Q1 $142.1M $141M -$0.50 -$0.39 -$0.12
02/15/2024 Q4 $183.7M $184M -$0.41 -$0.02 -$0.39
11/02/2023 Q3 $151.3M $153.6M -$0.79 -$0.04 -$0.75
08/03/2023 Q2 -- $146.8M -$0.53 -- --
05/03/2023 Q1 -- $134.3M -$0.44 -- --
02/15/2023 Q4 -- $156.2M -$0.15 -- --
11/02/2022 Q3 -- $131.1M -$0.37 -- --
08/08/2022 Q2 -- $114.6M -$0.57 -- --
05/04/2022 Q1 -- $114.5M -$0.38 -- --
02/16/2022 Q4 -- $143.5M -$0.16 -- --
11/03/2021 Q3 -- $125.3M -$0.15 -- --
08/04/2021 Q2 -- $115.8M -$0.10 -- --
05/05/2021 Q1 -- $105.8M -$0.11 -- --
02/17/2021 Q4 -- $112.2M -$3.87 -- --
11/10/2020 Q3 -- $71.8M -$0.65 -- --
08/11/2020 Q2 -- $42.9M -$0.41 -- --
05/11/2020 Q1 -- $71.9M -$0.22 -- --
02/18/2020 Q4 -- $75.3M -$0.07 -- --
11/07/2019 Q3 -- $61.2M -$0.10 -- --
06/30/2019 Q2 -- $55.8M -$0.11 -- --
03/31/2019 Q1 -- $53.6M -$0.04 -- --
12/31/2018 Q4 -- $50.6M -$0.79 -- --
09/30/2018 Q3 -- $36.6M -$0.16 -- --
06/30/2018 Q2 -- $31.7M -$0.06 -- --
03/31/2018 Q1 -- $27.4M -$0.16 -- --
12/31/2017 Q4 -- $25.6M -$0.04 -- --
09/30/2017 Q3 -- $18.5M -$0.05 -- --
06/30/2017 Q2 -- $14.9M -$0.04 -- --
03/31/2017 Q1 -- $12M -$0.07 -- --

10X Genomics, Inc. Earnings Questions

  • How Much did 10X Genomics, Inc. Generate in Revenue Last Quarter?

    10X Genomics, Inc. reported $149M worth of top line sales in its most recent quarter.

  • Did 10X Genomics, Inc. Beat Earnings Last Quarter?

    10X Genomics, Inc. announced earnings per share of -$0.22 which represents a miss of analyst forecast a -$0.07 per share.

  • Is 10X Genomics, Inc. Profitable?

    10X Genomics, Inc. reported $100.9M that represents $0.80 per share over the last quarter.

  • What is the Analyst Consensus for 10X Genomics, Inc. EPS Next Year?

    10X Genomics, Inc.'s earnings are forecast to decrease from -$1.52 per share to -$0.61 per share next year representing a decrease of -96.92%.

  • When is 10X Genomics, Inc.'s Earnings Date?

    10X Genomics, Inc.'s next earnings date is February 11, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
68
KOD alert for Dec 25

Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.

Buy
64
ZCSH alert for Dec 25

Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock